Literature DB >> 476231

The psychological effects of dopamine-beta-hydroxylase inhibition in normal subjects.

E Hartmann, M Keller-Teschke.   

Abstract

Acute administration of the dopamine-beta-hydroxylase (DBH) inhibitor, fusaric acid, combined with L-dopa, 500 mg, produced discernible psychological abnormalities in normal subjects. These were not found after L-dopa alone, or after placebo. The changes, lasting a few hours, were manifested by significant increases in "total psychopathology," and in a number of subscales on the Brief Psychiatric Rating Scale. Changes were also found in mood ratings on adjective checklists, and inkblot tests. A variety of effects were found on psychiatric interview. Since DBH does not occur in dopamine neurons, it is likely that the psychological effects were due to changes in dopamine or norepinephrine in norepinephrine neurons.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476231

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

Review 1.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

2.  Psychological effects of dopamine beta-hydroxylase inhibition: a failure to replicate.

Authors:  E Hartmann; M Oldfield; S Adelman; R Edelberg
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Psychosis and enuresis during disulfiram therapy.

Authors:  P A Sherif; K Krishna Murthy
Journal:  Indian J Psychiatry       Date:  2006-01       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.